New tool aims to measure life after stomach cancer surgery
NCT ID NCT07504913
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study translates and validates a Korean quality-of-life questionnaire (KOQUSS-40) for Spanish-speaking patients who had stomach cancer surgery. Researchers will enroll 505 adults who are at least one month past surgery and cancer-free. The goal is to create a reliable tool to measure how patients feel and function, which can be used in future clinical trials.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could provide a reliable Spanish-language tool to measure quality of life in stomach cancer survivors, helping future clinical trials better assess patient well-being.
- What could go wrong
- This is a validation study, not a treatment trial. It won't directly improve health, and the questionnaire may not capture all aspects of quality of life for every patient.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 505 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2025
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study patients will come from the centers that are currently part of the Spanish EURECCA Group for Esophagogastric Cancer (GEECEG) in Spain. The GEECEG was created in 2013 and collects prospective and validated information from all patients operated on for esophagogastric cancer in public hospitals of 8 Autonomous Communities. The registry records 116 variables that cover all the care stages of monitoring and treatment of patients with gastric cancer.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients operated on for gastric cancer with curative intent from 1 month postoperatively up to the last 5 years * Adult patients over 18 years old * No recurrence of the disease * Patients who have given their informed consent to participate in the Spanish EURECCA Registry of Esophagogastric Cancer and have signed the specific consent for the SPQUSS-4 study Exclusion Criteria: * First 30 days after surgery and/or patients with postoperative complications requiring more than 30 days of hospitalization. * Patients who do not give their consent to participate in the study will be excluded. * Patients with a history of other neoplasms. * Patients with disseminated gastric cancer or candidates for palliative surgery, as well as those patients who do not give their consent to participate.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gastric cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
5 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hospital Universitario Arnau de Vilanova
RECRUITINGLleida, Lleida, 25198, Spain
-
Hospital Universitario Germans Trias y Pujol
RECRUITINGBadalona, Barcelona, 08916, Spain
-
Hospital Universitario Puerto Real
RECRUITINGPuerto Real, Cadiz, 11510, Spain
-
Hospital Universitario San Pedro
RECRUITINGLogroño, La Rioja, 26006, Spain
-
Hospital Universitario Vall d'Hebron
RECRUITINGBarcelona, Barcelona, 08035, Spain
-
Hospital Universitario de Bellvitge
ACTIVE_NOT_RECRUITINGL'Hospitalet de Llobregat, Barcelona, 08907, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a personalized menu keep cancer patients stronger through chemotherapy?
- Nerve-Block procedure tested against severe pancreatic and stomach cancer pain
- Robotic surgery vs standard approaches: does the platform change cancer outcomes?
- Can a direct hit to tumors make immunotherapy work better?
- New antibody aims to preserve immune checkpoint while fighting cancer
- Engineered immune cells target two markers on Hard-to-Treat tumors